Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival - PubMed (original) (raw)
. 2009 Jul 15;15(14):4742-9.
doi: 10.1158/1078-0432.CCR-08-2514. Epub 2009 Jun 30.
Affiliations
- PMID: 19567592
- DOI: 10.1158/1078-0432.CCR-08-2514
Free article
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival
Anna Gustafsson et al. Clin Cancer Res. 2009.
Free article
Abstract
Purpose: Overexpression of the receptor tyrosine kinase Axl is implicated in several cancers. Therefore, we conducted this study to determine the expression of Axl and its ligand Gas6 in various renal cell carcinoma (RCC) types and in oncocytoma.
Experimental design: Real-time quantitative reverse transcription-PCR was used to quantify tumor mRNA levels for Axl and Gas6 in a cohort (n = 221) of RCC patients. Serum levels of soluble sAxl and Gas6 proteins were measured using specific ELISA assays (n = 282). The presence of Axl protein in tumor tissue was evaluated by immunohistochemistry (n = 294). Results were correlated to tumor-associated variables, clinical biochemical tests, and patient survival.
Results: Tumor Axl mRNA levels correlated independently to survival when assessed against tumor stage and grade. In the study group, the median cancer-specific survival of all RCC patients during 307 months of follow-up was 55 months (confidence interval, +/-40.4). The 25% of patients with lowest tumor Axl mRNA levels had significantly better survival than the rest (P = 0.0005), with 70% of the patients still alive at the end of follow-up. In contrast, in patients with medium-high Axl mRNA, only 25% were alive at the end of follow-up. Tumor Gas6 mRNA levels correlated to survival, tumor-associated variables, and disease severity as did serum levels of soluble sAxl and Gas6 protein. However, no correlation between Axl protein in tumor tissue and survival was found.
Conclusions: Axl and Gas6 expression in RCC are associated with tumor advancement and patient survival. In particular, low tumor Axl mRNA levels independently correlated with improved survival.
Similar articles
- Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
Gustafsson A, Boström AK, Ljungberg B, Axelson H, Dahlbäck B. Gustafsson A, et al. PLoS One. 2009 Oct 30;4(10):e7575. doi: 10.1371/journal.pone.0007575. PLoS One. 2009. PMID: 19888345 Free PMC article. - Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
Ishikawa M, Sonobe M, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Date H. Ishikawa M, et al. Ann Surg Oncol. 2013 Dec;20 Suppl 3(Suppl 3):S467-76. doi: 10.1245/s10434-012-2795-3. Epub 2012 Dec 16. Ann Surg Oncol. 2013. PMID: 23242819 Free PMC article. - Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers.
Sun WS, Fujimoto J, Tamaya T. Sun WS, et al. Ann Oncol. 2003 Jun;14(6):898-906. doi: 10.1093/annonc/mdg257. Ann Oncol. 2003. PMID: 12796028 - Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics.
Holstein E, Binder M, Mikulits W. Holstein E, et al. Int J Mol Sci. 2018 Dec 18;19(12):4111. doi: 10.3390/ijms19124111. Int J Mol Sci. 2018. PMID: 30567378 Free PMC article. Review. - Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.
Tanaka M, Siemann DW. Tanaka M, et al. Int J Mol Sci. 2021 Sep 15;22(18):9953. doi: 10.3390/ijms22189953. Int J Mol Sci. 2021. PMID: 34576116 Free PMC article. Review.
Cited by
- Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.
el Sayadi H, Pissaloux D, Alberti L, Tabone-Eglinger S, Ranchere D, Decouvelaere AV, Tabone E, Ray-Coquard I, Caux C, Fayette J, Blay JY. el Sayadi H, et al. Target Oncol. 2013 Dec;8(4):261-9. doi: 10.1007/s11523-012-0249-2. Epub 2013 Jan 25. Target Oncol. 2013. PMID: 23354874 - Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.
Boysen G, Bausch-Fluck D, Thoma CR, Nowicka AM, Stiehl DP, Cima I, Luu VD, von Teichman A, Hermanns T, Sulser T, Ingold-Heppner B, Fankhauser N, Wenger RH, Krek W, Schraml P, Wollscheid B, Moch H. Boysen G, et al. Neoplasia. 2012 Jun;14(6):535-46. doi: 10.1596/neo.12130. Neoplasia. 2012. PMID: 22806541 Free PMC article. - Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury.
Llacuna L, Bárcena C, Bellido-Martín L, Fernández L, Stefanovic M, Marí M, García-Ruiz C, Fernández-Checa JC, García de Frutos P, Morales A. Llacuna L, et al. Hepatology. 2010 Oct;52(4):1371-9. doi: 10.1002/hep.23833. Hepatology. 2010. PMID: 20730776 Free PMC article. - Axl as a mediator of cellular growth and survival.
Axelrod H, Pienta KJ. Axelrod H, et al. Oncotarget. 2014 Oct 15;5(19):8818-52. doi: 10.18632/oncotarget.2422. Oncotarget. 2014. PMID: 25344858 Free PMC article. Review. - Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
Gustafsson A, Boström AK, Ljungberg B, Axelson H, Dahlbäck B. Gustafsson A, et al. PLoS One. 2009 Oct 30;4(10):e7575. doi: 10.1371/journal.pone.0007575. PLoS One. 2009. PMID: 19888345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous